Statistics
Total Visits
Views | |
---|---|
A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women | 165 |
Total Visits per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women | 12 | 8 | 16 | 3 | 6 | 11 | 9 |
File Downloads
Views | |
---|---|
hdl_138889.pdf | 35 |
hdl_138889.pdf | 20 |
Top Country Views
Views | |
---|---|
United States | 51 |
Australia | 37 |
Vietnam | 9 |
China | 7 |
Singapore | 7 |
Hong Kong SAR China | 6 |
Belgium | 5 |
Ireland | 5 |
Bulgaria | 2 |
Sweden | 2 |
Top City Views
Views | |
---|---|
Ashburn | 11 |
New York | 10 |
Hanoi | 9 |
Boardman | 6 |
Central | 6 |
Brussels | 5 |
Clonee | 5 |
Singapore | 5 |
Brisbane | 3 |
Sydney | 3 |